Light Sciences Oncology Lines Up Extra $35M Financing For Targeted Cancer Treatment

Nov 5, 2009 1 related

Light Sciences Oncology, the Bellevue, WA-based developer of an unusual drug-device combo treatment for cancer, has put itself in position to raise $35 million for its product development through setting up a line of credit and... [read full story]

Add Comment

There are also 1 related articles

View all news articles about*:

Cancer Cancers Care CEO General Health Hyperplasia Issues Male Management Medicines Oncology Patients Pharmaceuticals Prostatic Remedies Senior Therapy Treatments

*Newstin tag cloud displays all featured persons, associated organizations, related topics, regions and companies

Send to a friend | Bookmark with

NewstinMap

Click to Open NewstinMap —

Visual Navigation

My Newstin

Context

Intelligent Data Fusion

About Us

Visit our corporate homepage to learn more about our company and products.

Light Sciences Oncology Lines Up Extra $35M Financing For Targeted Cancer Treatment

View other selected articles:

A Four-Gene Signature from NCI-60 Cell Line for Survival Prediction in Non-Small Cell Lung Cancer.

Research and Markets: Dermatology - A Colour Guide 2nd Edition Now Features 40 Conditions and...

Racial disparity in colon cancer survival not easily explained, UAB researchers say

Those pregnant at top of high-risk groups

International Editions